a thing called dow jones went up more than 100 points which is good for people who have money in the stocks. but a company called estee lauder's stocks went down a little bit after they shared how much money they made last quarter. Read from source...

In the article, Dow Jones index is mentioned to have gained more than 100 points but Estee Lauder's shares are reported to have fallen slightly after the company reported its Q4 results. This suggests a disconnect or conflicting information within the article, as the market performance doesn't necessarily reflect a company's financial results. The article also fails to provide any context or explanation for why Estee Lauder's shares fell, leaving readers with unanswered questions. The language used is also quite passive, which can be seen as an attempt to avoid taking a stance or making a judgment.

Bullish

Reasoning: The Dow Jones index gained more than 100 points, indicating a positive sentiment in the market. The report about Estee Lauder's fourth-quarter results, even though their shares fell slightly, also pointed towards a bullish sentiment. Furthermore, the rise in European shares and the Asia Pacific markets also contribute to the positive sentiment.

1. Estee Lauder Companies Inc (EL) - Shares fell slightly after the company reported its Q4 results. Sales growth of 7% YoY to $3.87 billion, beating the analyst consensus estimate of $3.83 billion. Estee Lauder's operating loss was $233 million, compared to a $5 million loss last year. Adjusted EPS of 64 cents beat the analyst consensus estimate of 27 cents.
- Risk: The stock may face volatility due to unexpected drops in future results.

2. Alzamend Neuro, Inc. (ALZN) - Shares shot up 262% to $7.37 after the company announced that it is partnering with Massachusetts General Hospital as its contract research organization to conduct the first-of-its-kind Phase II clinical study of AL001 for treatment of patients with PTSD.
- Risk: It's a relatively unknown company with a small market cap, so investors should proceed with caution and perform thorough research.

3. Virax Biolabs Group Limited (VRAX) - Shares got a boost, surging 152% to $5.37. Shares of vaccine and mpox-related stocks traded higher on continued strength after the WHO declared the virus a global health emergency.
- Risk: The stock is highly speculative, with limited trading volume and a small market cap.

4. Liquidia Corporation (LQDA) - Shares dropped 39% to $8.63 after the company announced that the FDA granted tentative approval of YUTREPIA inhalation powder to treat adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
- Risk: It's unclear why the stock is reacting negatively to this news, so investors should monitor the situation closely.

5. Theriva Biologics, Inc. (TOVX) - Shares were down 30% to $0.1411 after the company announced a 1-for-25 reverse stock split.
- Risk: Reverse stock splits can often indicate that a company is struggling, and investors should perform due diligence before investing.